Cargando…

Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims

OBJECTIVE: To compare physician-reported adherence of specific patients to oral second-generation antipsychotics vs. actual adherence rates determined from the patients’ pharmacy claims. METHODS: Claims data from the HealthCore Integrated Research Database identified patients with schizophrenia or b...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephenson, J J, Tuncelli, O, Gu, T, Eisenberg, D, Panish, J, Crivera, C, Dirani, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489041/
https://www.ncbi.nlm.nih.gov/pubmed/22574724
http://dx.doi.org/10.1111/j.1742-1241.2012.02918.x
_version_ 1782248710841827328
author Stephenson, J J
Tuncelli, O
Gu, T
Eisenberg, D
Panish, J
Crivera, C
Dirani, R
author_facet Stephenson, J J
Tuncelli, O
Gu, T
Eisenberg, D
Panish, J
Crivera, C
Dirani, R
author_sort Stephenson, J J
collection PubMed
description OBJECTIVE: To compare physician-reported adherence of specific patients to oral second-generation antipsychotics vs. actual adherence rates determined from the patients’ pharmacy claims. METHODS: Claims data from the HealthCore Integrated Research Database identified patients with schizophrenia or bipolar disorder with ≥1 oral second-generation antipsychotic prescription. The prescribing physicians were identified from the pharmacy claims and asked to complete an Internet survey assessing their perception of medication adherence for 1–2 of their patients and their beliefs regarding adherence to second-generation antipsychotics in general for a 1-year period. Adherence to second-generation antipsychotics was determined for each patient by pharmacy claims for the same period. Physician survey data were merged with patient claims data via unique patient identifiers, and physician-reported adherence rates were compared with claims-based rates as measured by the medication possession ratio. RESULTS: One hundred and fifty-three physicians responded to the survey, representing 214 patients (44 with claims for schizophrenia, 162 with bipolar disorder, 8 with claims for bipolar disorder and schizophrenia). Most physicians (60%) had no formal adherence training. More than two-thirds (68%) reported emphasising the importance of adherence and reported approximately 76% of their patients were adherent (≥71% of the time). In the schizophrenia group, 16 of 17 (94%) patients with low-to-moderate (≤70%) adherence levels had high (≥71%) physician-estimated adherence. In the bipolar disorder group, 62 of 92 (67%) patients with low-to-moderate adherence levels had high physician-estimated adherence. CONCLUSIONS/INTERPRETATION: These analyses suggest that, even when physicians are asked about specific patients in their practice, there is discordance between physician perceptions and adherence as measured through pharmacy claims. This disparity may delay appropriate interventions, potentially contributing to relapses.
format Online
Article
Text
id pubmed-3489041
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-34890412012-11-05 Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims Stephenson, J J Tuncelli, O Gu, T Eisenberg, D Panish, J Crivera, C Dirani, R Int J Clin Pract Psychiatry OBJECTIVE: To compare physician-reported adherence of specific patients to oral second-generation antipsychotics vs. actual adherence rates determined from the patients’ pharmacy claims. METHODS: Claims data from the HealthCore Integrated Research Database identified patients with schizophrenia or bipolar disorder with ≥1 oral second-generation antipsychotic prescription. The prescribing physicians were identified from the pharmacy claims and asked to complete an Internet survey assessing their perception of medication adherence for 1–2 of their patients and their beliefs regarding adherence to second-generation antipsychotics in general for a 1-year period. Adherence to second-generation antipsychotics was determined for each patient by pharmacy claims for the same period. Physician survey data were merged with patient claims data via unique patient identifiers, and physician-reported adherence rates were compared with claims-based rates as measured by the medication possession ratio. RESULTS: One hundred and fifty-three physicians responded to the survey, representing 214 patients (44 with claims for schizophrenia, 162 with bipolar disorder, 8 with claims for bipolar disorder and schizophrenia). Most physicians (60%) had no formal adherence training. More than two-thirds (68%) reported emphasising the importance of adherence and reported approximately 76% of their patients were adherent (≥71% of the time). In the schizophrenia group, 16 of 17 (94%) patients with low-to-moderate (≤70%) adherence levels had high (≥71%) physician-estimated adherence. In the bipolar disorder group, 62 of 92 (67%) patients with low-to-moderate adherence levels had high physician-estimated adherence. CONCLUSIONS/INTERPRETATION: These analyses suggest that, even when physicians are asked about specific patients in their practice, there is discordance between physician perceptions and adherence as measured through pharmacy claims. This disparity may delay appropriate interventions, potentially contributing to relapses. Blackwell Publishing Ltd 2012-06 /pmc/articles/PMC3489041/ /pubmed/22574724 http://dx.doi.org/10.1111/j.1742-1241.2012.02918.x Text en © 2012 Blackwell Publishing Ltd http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopenOnlineOpen_Terms
spellingShingle Psychiatry
Stephenson, J J
Tuncelli, O
Gu, T
Eisenberg, D
Panish, J
Crivera, C
Dirani, R
Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
title Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
title_full Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
title_fullStr Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
title_full_unstemmed Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
title_short Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
title_sort adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489041/
https://www.ncbi.nlm.nih.gov/pubmed/22574724
http://dx.doi.org/10.1111/j.1742-1241.2012.02918.x
work_keys_str_mv AT stephensonjj adherencetooralsecondgenerationantipsychoticmedicationsinpatientswithschizophreniaandbipolardisorderphysiciansperceptionsofadherencevspharmacyclaims
AT tuncellio adherencetooralsecondgenerationantipsychoticmedicationsinpatientswithschizophreniaandbipolardisorderphysiciansperceptionsofadherencevspharmacyclaims
AT gut adherencetooralsecondgenerationantipsychoticmedicationsinpatientswithschizophreniaandbipolardisorderphysiciansperceptionsofadherencevspharmacyclaims
AT eisenbergd adherencetooralsecondgenerationantipsychoticmedicationsinpatientswithschizophreniaandbipolardisorderphysiciansperceptionsofadherencevspharmacyclaims
AT panishj adherencetooralsecondgenerationantipsychoticmedicationsinpatientswithschizophreniaandbipolardisorderphysiciansperceptionsofadherencevspharmacyclaims
AT criverac adherencetooralsecondgenerationantipsychoticmedicationsinpatientswithschizophreniaandbipolardisorderphysiciansperceptionsofadherencevspharmacyclaims
AT diranir adherencetooralsecondgenerationantipsychoticmedicationsinpatientswithschizophreniaandbipolardisorderphysiciansperceptionsofadherencevspharmacyclaims